LHC — Q1 2021 Earnings Presentation
36 slides from LHC's earnings presentation, May 6, 2021
Slide 1: Supplemental Financial Information First Quarter Ended March 31, 2021
Supplemental Financial Information First Quarter Ended March 31, 2021 May 5, 2021 Exhibit 99.2
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company. Words such as “anticipate,” “expect,” “project,” “intend,”
Slide 3: Table of Contents
Table of Contents 3 Overview & Policy Tailwinds 4 - 8 Differentiated Strategies 9 - 16 First Quarter Consolidated Results Segment Results Guidance, Liquidity & Outlook Appendix LHC Group Overview Commentary on Q1 2021 At Home Care Policy Tailwinds Differentiated Strategy Leading to Quality Growth Mu
Slide 4: Overview & Policy Tailwinds
4 Overview & Policy Tailwinds
Slide 5: LHC Group Overview
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC Group Overview 5 531 home health locations 60% Of U.S. population aged 65+ included in service area 120 hospice locations 129 home & community based services locations 12 Long term acute care hospitals
Slide 6: Commentary on Q1 2021
Organic growth in admissions for home health locations decreased -0.4% for the quarter compared to the same period in 2020 with 5.9% same store sequential growth over the fourth quarter of 2020. Our non-Medicare episodic same store admissions increased 22.6% in Q1 as compared to Q1 in 2020 with 25.1
Slide 7: At Home Care Policy Tailwinds
On April 14, President Biden signed into law a bill extending relief through year end for the home health, hospice and other health care sectors from the statutory Medicare 2% sequestration provider payment cut. On April 20, Sec. of Health and Human Services Becerra signed an Administrative Order ex
Slide 8: At Home Care Policy Tailwinds (continued)
Senator Casey introduced legislation known as the PACE Plus Act significantly expanding Programs for All-Inclusive Care for the Elderly (PACE), a Medicare and Medicaid program that helps keep people in their homes and communities instead of nursing homes. Congress has previously acknowledged the val
Slide 9: Differentiated Strategies
9 Differentiated Strategies
Slide 10: Differentiated Strategy Leading to Quality Growth
Joint ventures drive organic growth and margin improvement Same store growth for JV locations averaged 200 basis points higher than non-JV locations for the years 2016-2019. Revenue growth rate for JVs average 10% to 15% in year 2 and 3. Margins for JV locations average 100 to 200 basis points highe
Slide 11: Multiple Organic and Inorganic Growth Levers
Multiple Organic and Inorganic Growth Levers Organic Growth Acquisition Growth Upside Opportunities Move to taking risk on total cost of HH from MA plans and health systems Grow Imperium ACOs and extend proven record of managing post-acute network building Create high performing post-acute networks
Slide 12: Building Blocks of Long-Term Earnings Growth
Building Blocks of Long-Term Earnings Growth Developing alternative reimbursement models (PMPM; Case Rate; episodic) with regional and national payors, demonstrating continued progression beyond fee-for-service and per visit relationships Revising contracts and developing processes with major payors
Slide 13: Recruiting and Retention
Recruiting and Retention 13 We continue to see positive trends in recruiting and retention. We have two consecutive quarters in which we have hired a record number of employees while our turnover has continued to decrease. Our headcount statistics are a direct correlation and validation to our compa
Slide 14: Sequential Operational Trends Continue to Improve
Sequential Operational Trends Continue to Improve 14 Home Health, Hospice and HCBS Trends
Slide 15: Home Health and Hospice Growth
15 Home Health and Hospice Growth Same Store Organic Admission Growth over Prior-Year Periods Sequential Same Store Organic Admission Growth New Physician Home Health Referral Sources
Slide 16: Industry-Leading Quality and Patient Satisfaction
Industry-Leading Quality and Patient Satisfaction 85% of LHC Group same-store providers have CMS 4 stars or greater for quality 16 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approxim
Slide 17: First Quarter Consolidated Results
17 First Quarter Consolidated Results
Slide 18: 2021 Adjusted Consolidated Results
2021 Adjusted Consolidated Results 18
Slide 19: Adjusted Consolidated Results – 2021 vs 2020
Adjusted Consolidated Results – 2021 vs 2020 19
Slide 20: Adjustments to Net Income
Adjustments to Net Income ‘cquistion and deo nse5 (1 $1,510, ‘osresfroraton/cnsolaton 468 {COVID-19 PPE, supplies and wages 11,990 78 Total 3267 $456 ‘Acquistion and de novo expenses $1106 leet 13 38 coup. rceariezsel eee 5982 208 ES Act ax benef 2 (2210 Total Ta, ‘S137 Acquis de est $008 Gosresfeoe
Slide 21: Segment Results
21 Segment Results
Slide 22: Three Months Ended March 31, 2021 Adjusted Segment Results
Three Months Ended March 31, 2021 Adjusted Segment Results 22
Slide 23: Home Health Segment Adjusted Segment Results – 2021 vs 2020
23 Home Health Segment Adjusted Segment Results – 2021 vs 2020 For the three months ended March 31, 2021, consolidated Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) increased $15.8 million and improved 410 basis points as a percentage of revenue as compared to Q1
Slide 24: Home Health Revenue Factors
24 Home Health Revenue Factors The first 30-day period in an episode is referred to as P1 or Period 1. All other subsequent 30-day periods are referred to as P2. P1 is considered an early episode and receives a higher payment than a P2. * April is an estimate
Slide 25: Hospice Segment Adjusted Segment Results – 2021 vs 2020
25 Hospice Segment Adjusted Segment Results – 2021 vs 2020 For the three months ended March 31, 2021, consolidated EBITDA increased $0.6 million and improved 60 basis points as a percentage of revenue as compared to Q1 2020. The increase is due to a 3.9% increase in patient average daily census in Q
Slide 26: Home and Community Based Services Segment Adjusted Results
26 Home and Community Based Services Segment Adjusted Segment Results – 2021 vs 2020 For the three months ended March 31, 2021, consolidated EBITDA increased $4.0 million and improved 810 basis points as a percentage of revenue as compared to Q1 2020. The increase is due to $2.4 million in improved
Slide 27: Facility-Based Services Segment Adjusted Results – 2021 vs 2020
Facility-Based Services Segment Adjusted Segment Results – 2021 vs 2020 27 For the three months ended March 31, 2021, consolidated EBITDA increased $2.5 million and improved 720 basis points as a percentage of revenue as compared to Q1 2020. The increase is due to a 6.1% increase in patient average
Slide 28: Healthcare Innovations Segment Adjusted Results
Home Care Innovations Segment Adjusted Segment Results – 2021 vs 2020 28 For the three months ended March 31, 2021, consolidated EBITDA increased $0.6 million and improved 860 basis points as a percentage of revenue as compared to Q1 2020. The increase is due to effective cost management strategies
Slide 29: Guidance, Liquidity & Outlook
29 Guidance, Liquidity & Outlook
Slide 30: Full Year 2021 Guidance
Assumptions Guidance updated for sequestration suspension extension to December 31, 2021, and extension of the Public Health Emergency through July 20, 2021. Estimated effective tax rate of 26.0% to 26.5% for full year 2021. 8% to 10% organic growth in home health admissions for the year. 8% to 10%
Slide 31: Debt and Liquidity Metrics
Debt and Liquidity Metrics 31
Slide 32: Focus for 2021
Focus for 2021 32 Maintain disciplined capital allocation with new joint ventures and other M&A activity. Accelerate unlocking the potential of our co-location and tri-location strategies. Maintain proactive posture to COVID-19 pandemic response. Continue to be a leader in the industry in quality an
Slide 33: Appendix
33 Appendix
Slide 34: Non-GAAP Reconciliations
Non-GAAP Reconciliations (Amounts in thousands, unaudited) 34 Footnotes are on page 23
Slide 35: Non-GAAP Reconciliations: Adjusted EBITDA
Non-GAAP Reconciliations (Amounts in thousands, unaudited) 35 Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
Slide 36: It all about helping people.
It all about helping people.